Price movement over the last 24 hours
Align Technology, Inc. vs iShares S&P GSCI Commodity-Indexed Trust ETF — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while iShares S&P GSCI Commodity-Indexed Trust ETF trades at $29.56. Which is the better fit depends on your goals.
| ALGN | GSG | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $207.19 | $34.77 |
52-Week Low | $124.88 | $22.06 |
Enterprise Value | $11.92B | — |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
GSG trades at $29.46, down 0.27% on the day, with a bullish technical signal driven by moving averages. Key support and resistance cluster around $29 and $30. Recent news highlights commodities as a leading market theme, which may influence sector interest. Financial ratios are not provided in the available data, limiting fundamental assessment.
The outlook hinges on commodity market trends and institutional positioning, with upside potential if bullish momentum holds above $30. Risks include reliance on broader commodity cycles and lack of visible fundamental metrics. Investor sentiment appears cautiously optimistic amid sector tailwinds.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →GSG is a diversified commodity ETF that tracks the S&P GSCI Total Return Index. It provides exposure to a broad basket of futures, including energy, metals, and agriculture, with a significant weighting toward the energy sector.
Read more on GSG →